Trial intelligence / Profile preview

Endogenous Opioid Activity and Affective State in Insulin Resistant Women

NCT02069379Phase 4Completed

Sponsor
University of Michigan
Start
Jul 2014
Primary completion
Mar 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of metformin in insulin resistance (IR), metabolic syndrome, sponsored by University of Michigan. Started Jul 2014; status: completed.

02

Drugs

metformin
03

Conditions

insulin resistance (IR)metabolic syndrome

Beyond the preview

Go deeper on NCT02069379.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02069379.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call